JP2009522579A5 - - Google Patents

Download PDF

Info

Publication number
JP2009522579A5
JP2009522579A5 JP2008549576A JP2008549576A JP2009522579A5 JP 2009522579 A5 JP2009522579 A5 JP 2009522579A5 JP 2008549576 A JP2008549576 A JP 2008549576A JP 2008549576 A JP2008549576 A JP 2008549576A JP 2009522579 A5 JP2009522579 A5 JP 2009522579A5
Authority
JP
Japan
Prior art keywords
polypeptide
cell
orai
test agent
nfat regulatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008549576A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009522579A (ja
JP5881270B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/000280 external-priority patent/WO2007081804A2/en
Publication of JP2009522579A publication Critical patent/JP2009522579A/ja
Publication of JP2009522579A5 publication Critical patent/JP2009522579A5/ja
Application granted granted Critical
Publication of JP5881270B2 publication Critical patent/JP5881270B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008549576A 2006-01-05 2007-01-05 Nfatの制御因子 Active JP5881270B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75693406P 2006-01-05 2006-01-05
US60/756,934 2006-01-05
PCT/US2007/000280 WO2007081804A2 (en) 2006-01-05 2007-01-05 Regulators of nfat

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2013268702A Division JP2014128267A (ja) 2006-01-05 2013-12-26 Nfatの制御因子
JP2014000164A Division JP6025758B2 (ja) 2006-01-05 2014-01-06 Nfatの制御因子

Publications (3)

Publication Number Publication Date
JP2009522579A JP2009522579A (ja) 2009-06-11
JP2009522579A5 true JP2009522579A5 (enExample) 2010-06-24
JP5881270B2 JP5881270B2 (ja) 2016-03-09

Family

ID=38256924

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008549576A Active JP5881270B2 (ja) 2006-01-05 2007-01-05 Nfatの制御因子
JP2013268702A Withdrawn JP2014128267A (ja) 2006-01-05 2013-12-26 Nfatの制御因子
JP2014000164A Active JP6025758B2 (ja) 2006-01-05 2014-01-06 Nfatの制御因子

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013268702A Withdrawn JP2014128267A (ja) 2006-01-05 2013-12-26 Nfatの制御因子
JP2014000164A Active JP6025758B2 (ja) 2006-01-05 2014-01-06 Nfatの制御因子

Country Status (5)

Country Link
US (4) US8399185B2 (enExample)
EP (2) EP1984400B1 (enExample)
JP (3) JP5881270B2 (enExample)
CA (1) CA2636417C (enExample)
WO (1) WO2007081804A2 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1984400B1 (en) 2006-01-05 2012-11-28 Immune Disease Institute, Inc. Regulators of nfat
EP2013627A4 (en) * 2006-04-10 2009-08-05 Queens Medical Ct CRAC-MODULATORS AND ITS USE IN THE ACTIVE SUBSTANCE
WO2007139926A2 (en) * 2006-05-26 2007-12-06 The Regents Of The University Of California Crac channel and modulator screening methods
WO2008148108A1 (en) 2007-05-24 2008-12-04 Calcimedica, Inc. Calcium channel proteins and uses thereof
CA2699157A1 (en) 2007-09-10 2009-03-19 Calcimedica, Inc. Compounds that modulate intracellular calcium
GB0800938D0 (en) * 2008-01-18 2008-02-27 Ge Healthcare Uk Ltd Multiplex cell signalling assay
EP2321303B1 (en) 2008-08-27 2019-11-27 Calcimedica, Inc. Compounds that modulate intracellular calcium
US8394778B1 (en) 2009-10-08 2013-03-12 Immune Disease Institute, Inc. Regulators of NFAT and/or store-operated calcium entry
TW201129379A (en) 2009-11-20 2011-09-01 Amgen Inc Anti-Orai1 antigen binding proteins and uses thereof
WO2012144972A2 (en) * 2010-01-19 2012-10-26 The General Hospital Corporation Methods to inhibit neurodegeneration
EP2563759B1 (en) 2010-04-27 2022-04-06 Calcimedica, Inc. Compounds that modulate intracellular calcium
US10703722B2 (en) 2010-04-27 2020-07-07 Calcimedica, Inc. Compounds that modulate intracellular calcium
PT2563776T (pt) 2010-04-27 2016-09-19 Calcimedica Inc Compostos que modulam o cálcio intracelular
KR101204620B1 (ko) 2010-08-06 2012-11-27 가톨릭대학교 산학협력단 혈관 형성 관련 질환 진단용 마커 및 이의 용도
CA2809830C (en) 2010-08-27 2019-09-10 Calcimedica, Inc. Compounds comprising n-acyl-2-amino-1,3-thiazole for modulating intracellular calcium
US9567580B2 (en) 2010-10-08 2017-02-14 Anjana Rao Regulators of NFAT and/or store-operated calcium entry
US20140294873A1 (en) * 2011-11-08 2014-10-02 Children Medical Center Corporation Small molecule screen for inhibitors of nfat: ap-1: dna interactions
US9512116B2 (en) 2012-10-12 2016-12-06 Calcimedica, Inc. Compounds that modulate intracellular calcium
US9611263B2 (en) 2013-10-08 2017-04-04 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2015196068A2 (en) * 2014-06-20 2015-12-23 Geisinger Clinic Loss of dyrk1b gene function to inhibit metabolic syndrome including diabetes and hypertension
RS61588B1 (sr) 2014-08-07 2021-04-29 Daiichi Sankyo Co Ltd Anti-orai1 antitelo
JP6366415B2 (ja) * 2014-08-07 2018-08-01 株式会社 資生堂 Orai3遺伝子発現抑制剤又はORAI3タンパク質の機能抑制剤を含む細胞賦活剤
EP3778595B1 (en) 2015-02-27 2021-08-25 Calcimedica, Inc. Pancreatitis treatment
EP3331525B1 (en) 2015-08-07 2020-10-07 Calcimedica, Inc. Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury
KR20200071082A (ko) 2017-10-17 2020-06-18 리젠 파마슈티컬스 소시에떼 아노님 식도암을 치료하기 위한 crac 채널 조절제
WO2019082124A1 (en) 2017-10-26 2019-05-02 Rhizen Pharmaceuticals Sa COMPOSITION AND METHOD FOR THE TREATMENT OF LARGE B-CELL DIFFUSED LYMPHOMA
BR112020008219A2 (pt) 2017-10-30 2020-10-27 Rhizen Pharmaceuticals Sa moduladores de canal de cálcio ativado por liberação de cálcio para tratar cânceres hematológicos e sólidos
MX2021003094A (es) 2018-09-14 2021-05-12 Rhizen Pharmaceuticals A G Composiciones que comprenden un inhibidor de crac y un corticosteroide y métodos de uso de estas.
WO2020141106A1 (en) * 2019-01-03 2020-07-09 Kemijski Institut Engineered externally regulated artificial transcription regulatory system based on engineered nfat
JP2023526505A (ja) 2020-05-20 2023-06-21 カルシメディカ,インク. 急性腎障害を治療するための方法および組成物
US12522589B2 (en) 2020-11-13 2026-01-13 Calcimedica, Inc. Synthesis of CRAC channel inhibitors
CN112458149B (zh) * 2020-12-03 2021-10-08 北京东方百泰生物科技股份有限公司 一种以cd3为靶点的抗体药物对t细胞激活程度的检测方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4109496A (en) 1977-12-20 1978-08-29 Norris Industries Trapped key mechanism
US4868103A (en) 1986-02-19 1989-09-19 Enzo Biochem, Inc. Analyte detection by means of energy transfer
US5080891A (en) 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
EP0552108B1 (en) 1992-01-17 1999-11-10 Lakowicz, Joseph R. Energy transfer phase-modulation fluoro-immunoassay
CA2148252C (en) 1992-10-30 2007-06-12 Roger Brent Interaction trap system for isolating novel proteins
US20040002117A1 (en) 1998-02-12 2004-01-01 Hogan Patrick G. Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases
EP0976823A1 (de) 1998-07-22 2000-02-02 Helge Dr. Völkel Rekombinantes Expressions System und Hoch-Durchsatz BioAssay für die therapeutische Anwendung von Calcineurin-A-Alpha, Calcineurin-A-Beta, Calcineurin-A-Gamma, Calcineurin-B und Copper/Zinc-Superoxide Dismutase bzw. zur Identifizierung von Pharmazeutika
EP1074617A3 (en) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
US6485924B2 (en) 1999-12-07 2002-11-26 Boehringer Ingelheim International Gmbh Method for identifying inhibitors of cytokinesis
US20040219521A1 (en) 2000-01-21 2004-11-04 Tang Y. Tom Novel nucleic acids and polypeptides
CN1177864C (zh) 2000-06-20 2004-12-01 上海市肿瘤研究所 在肝癌组织中具有表达差异的新的人蛋白及其编码序列
WO2002030976A1 (en) 2000-10-11 2002-04-18 The University Of Melbourne Cell control nucleic acids and proteins
US6783969B1 (en) * 2001-03-05 2004-08-31 Nuvelo, Inc. Cathepsin V-like polypeptides
WO2003052049A2 (en) 2001-07-09 2003-06-26 Incyte Genomics, Inc. Molecules for disease detection and treatment
NZ513755A (en) 2001-08-24 2001-09-28 Ann Rachel Holmes Protein expression system in yeast comprising a vector encoding a heterologous membrane protein and its application in screening for drugs
EP1293569A3 (en) 2001-09-14 2004-03-31 Research Association for Biotechnology Full-length cDNAs
US20050107588A1 (en) * 2001-11-13 2005-05-19 Duggan Brendan M. Receptors and membrane-associated proteins
JP2006507841A (ja) 2002-11-14 2006-03-09 ダーマコン, インコーポレイテッド 機能的siRNAおよび超機能的siRNA
WO2004078995A2 (en) * 2003-03-04 2004-09-16 Neurogenetics, Inc. Methods of modulating and of identifying agents that modulate intracellular calcium
WO2005019258A2 (en) 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
JP2008518610A (ja) 2004-11-03 2008-06-05 アルマック ダイアグノスティックス リミテッド トランスクリプトームマイクロアレイ技法およびそれを使用する方法
CA2606341A1 (en) 2005-04-29 2006-11-09 Genizon Biosciences Inc. Genemap of the human genes associated with crohn's disease
US7481994B2 (en) 2005-06-07 2009-01-27 The Board Of Trustees Of The Leland Stanford Junior University Calcium biosensor polypeptides and methods of use
WO2007047796A2 (en) 2005-10-17 2007-04-26 Institute For Systems Biology Tissue-and serum-derived glycoproteins and methods of their use
EP1984400B1 (en) 2006-01-05 2012-11-28 Immune Disease Institute, Inc. Regulators of nfat
EP2013627A4 (en) 2006-04-10 2009-08-05 Queens Medical Ct CRAC-MODULATORS AND ITS USE IN THE ACTIVE SUBSTANCE
WO2007139926A2 (en) 2006-05-26 2007-12-06 The Regents Of The University Of California Crac channel and modulator screening methods
WO2008148108A1 (en) 2007-05-24 2008-12-04 Calcimedica, Inc. Calcium channel proteins and uses thereof
JP5559049B2 (ja) 2007-07-10 2014-07-23 チルドレンズ メディカル センター コーポレーション 間質相互作用分子ノックアウトマウス及びその使用
US20090074750A1 (en) 2007-09-18 2009-03-19 Onn Brandman Regulator of basal cellular calcium concentration and methods of use
JP2011515376A (ja) 2008-03-20 2011-05-19 ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー 病的血栓形成に必須であるカルシウムセンサSTIM1及び血小板SOCチャネルOrai1(CRACM1)
US20120165265A1 (en) 2009-02-26 2012-06-28 Dolmetsch Ricardo E Calcium Signaling Modulators Involving STIM and ORAI Proteins

Similar Documents

Publication Publication Date Title
JP2009522579A5 (enExample)
RU2016102922A (ru) Способы идентификации, изоляции и применения рецепторов пахучих веществ и ароматов
Goodman et al. How Caenorhabditis elegans senses mechanical stress, temperature, and other physical stimuli
MY153980A (en) Method for identifying allergenic proteins and peptides
Watanabe et al. Type XVII collagen coordinates proliferation in the interfollicular epidermis
Van den Bos et al. Phosphorylation of MRP14, an S100 protein expressed during monocytic differentiation, modulates Ca (2+)-dependent translocation from cytoplasm to membranes and cytoskeleton
BRPI0618391A2 (pt) método para identificar um nucleotìdeo individual, método para seqüenciar uma seqüência de ácido nucleico alvo, e, kit para seqüenciar um ácido nucleico
RU2009129185A (ru) Способы и мишени для идентификации соединений для регуляции риновирусной инфекции
CA2483961A1 (en) Methods of screening for trpm4b modulators
DK1495330T3 (da) Fremgangsmåde til at identificere forbindelser, som påvirker transmembran-proteiner
JP2006519020A5 (enExample)
CL2007003785A1 (es) Acidos nucleicos aislados de bacillus thuringensis, construccion y celulas huesped que comprenden dichos acidos nucleicos, polipeptidos aislados con actividad pesticida codificados por estos polinucleoticos, metodo de produccion de dichas proteinas con actividad pesticida, y para controlar una plaga de insectos.
WO2006138433A3 (en) Induction of cell differentiation by class i bhlh polypeptides
JP2017528120A5 (enExample)
DE60233147D1 (de) Verwendung von hmgb1 zur aktivierung dendritischer zellen
JP2009533065A5 (enExample)
JP2009539377A5 (enExample)
DE602007004143D1 (de) Verfahren zur Beurteilung der Lebensfähigkeit von Embryos
AU2008232699A8 (en) High expression clones of mammalian cells with fluorescent protein A or G
WO2009141352A3 (en) Risk analysis in patients with and without metabolic syndrome
JP2006526389A5 (enExample)
JP2005535289A5 (enExample)
WO2008147206A3 (en) Means and methods for classifying samples of multiple sclerosis patients
WO2005035713A3 (en) Alternatively spliced variants of human cox1
WO2007138066A3 (en) Method of screening for compounds that alter skin and/or hair pigmentation